Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
NICABATE MINI LOZENGES nicotine 4 mg (as polacrilex) mint flavour lozenge tube (new formulation), GlaxoSmithKline Consumer Healthcare Australia Pty Ltd, CON-970
Product name
NICABATE MINI LOZENGES nicotine 4 mg (as polacrilex) mint flavour lozenge tube (new formulation)
Sponsor name
GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
Consent start
Consent no.
CON-970
Standard
The requirements of Therapeutic Goods Order No. 92 - Standard for label of non-prescription medicines (TGO 92), paragraphs 9(7)(i) and 10(7).
Non-compliance with standard
The product is non-compliant in that the container labels do not conform with
the following requirements The product name and active ingredient name and
quantity are displayed in a text size of less than 2 mm in height; and the
quantity of the medicine in the container is displayed in a text size of less
than 1.5 mm.
Therapeutic product type
Over-the-counter medicines